BSE - Delayed Quote INR

Supriya Lifescience Limited (SUPRIYA.BO)

700.15
-13.65
(-1.91%)
At close: June 4 at 3:29:44 PM GMT+5:30
Loading Chart for SUPRIYA.BO
  • Previous Close 713.80
  • Open 717.40
  • Bid 698.65 x --
  • Ask 702.40 x --
  • Day's Range 696.95 - 718.15
  • 52 Week Range 336.00 - 841.70
  • Volume 9,462
  • Avg. Volume 27,151
  • Market Cap (intraday) 56.35B
  • Beta (5Y Monthly) 0.23
  • PE Ratio (TTM) 30.00
  • EPS (TTM) 23.34
  • Earnings Date Aug 8, 2025 - Aug 9, 2025
  • Forward Dividend & Yield 0.80 (0.11%)
  • Ex-Dividend Date Sep 20, 2024
  • 1y Target Est 843.00

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India.

www.supriyalifescience.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: SUPRIYA.BO

View More

Performance Overview: SUPRIYA.BO

Trailing total returns as of 6/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

SUPRIYA.BO
5.37%
S&P BSE SENSEX (^BSESN)
3.66%

1-Year Return

SUPRIYA.BO
107.57%
S&P BSE SENSEX (^BSESN)
12.37%

3-Year Return

SUPRIYA.BO
95.77%
S&P BSE SENSEX (^BSESN)
45.24%

5-Year Return

SUPRIYA.BO
64.74%
S&P BSE SENSEX (^BSESN)
138.37%

Compare To: SUPRIYA.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SUPRIYA.BO

View More

Valuation Measures

Annual
As of 6/3/2025
  • Market Cap

    57.45B

  • Enterprise Value

    56.70B

  • Trailing P/E

    30.57

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.25

  • Price/Book (mrq)

    5.76

  • Enterprise Value/Revenue

    8.14

  • Enterprise Value/EBITDA

    20.96

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.99%

  • Return on Assets (ttm)

    14.77%

  • Return on Equity (ttm)

    20.74%

  • Revenue (ttm)

    6.96B

  • Net Income Avi to Common (ttm)

    1.88B

  • Diluted EPS (ttm)

    23.34

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    791.54M

  • Total Debt/Equity (mrq)

    0.54%

  • Levered Free Cash Flow (ttm)

    -203.5M

Research Analysis: SUPRIYA.BO

View More

Company Insights: SUPRIYA.BO

Research Reports: SUPRIYA.BO

View More

People Also Watch